Innovation and commercialisation in the stem cell industries in Australia: State strategies and other opportunities to build a competitive position in the global stem cell economy
Recent research in the social studies of stem cell science has demonstrated that there is (a) a significant global economy emerging around stem cell science, and (b) that individual states are competing fiercely in an effort to obtain leadership in this global stem cell economy. Over the last several years, the governments of the United Kingdom, China, India, Canada, Singapore and Australia (among others), have been attempting to leverage the process of innovation in stem cell science by implementing a variety of strategies including, but not limited to: dedicated funding programmes, the introduction of specific licensing systems, the implementation of new regulations for human cell-based material, emulating US-based venture capital, and encouraging entrepreneurship and spin-off developments. What remains to be seen though, is how effective such attempts actually will be in encouraging the commercial development of nationally oriented stem cell industries. Given that the relationship between innovation and commercialisation is unique to national and regional contexts, as well as unique to specific industries, this article discusses the specific strategies adopted in developing the stem cell industries in Australia and highlights some of the pros and cons with a government interventionist approach to developing global economic advantage from national and regional innovation.
- 원문이 없습니다.
유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.
원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.
NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.
- 이 논문과 함께 출판된 논문 + 더보기